Retrospective Analysis of Recurrence and Ways of Metastasis in Squamous Cell Carcinoma of the Maxilla
Completed
- Conditions
- C06.9Mouth, unspecified
- Registration Number
- DRKS00006784
- Lead Sponsor
- niklinik FreiburgKlinik für Mund-, Kiefer- und Gesichtschirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
OSCC of the Maxilla treated primarily with surgery from 2000 until June 2013
Exclusion Criteria
Patients were excluded in case of malignancies other than OSCC, secondary OSCC, CUP Syndrome, other location of tumor, primary non-surgical therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive recurrence in maxillary squamous cell carcinoma as analyzed in DRKS00006784?
How does metastatic spread in maxillary SCC compare to other head and neck cancers in DRKS00006784 findings?
Which biomarkers correlate with prognosis in maxillary squamous cell carcinoma according to DRKS00006784 data?
What adverse events are associated with maxillary SCC recurrence monitoring in observational studies like DRKS00006784?
What targeted therapies or immunotherapies show promise for preventing maxillary SCC recurrence post-surgery?